• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

个性化预后见解:用于胆囊癌生存预测的CONUT-GBRS

Individualized Prognostic Insights: CONUT-GBRS for Survival Prediction in Gallbladder Cancer.

作者信息

Yang Si-Qi, Zou Rui-Qi, Dai Yu-Shi, Wang Jun-Ke, Ma Wen-Jie, Hu Hai-Jie, Li Fu-Yu

机构信息

Division of Biliary Tract Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.

出版信息

Cancer Med. 2025 Sep;14(18):e71203. doi: 10.1002/cam4.71203.

DOI:10.1002/cam4.71203
PMID:40936483
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12426482/
Abstract

BACKGROUND

The most suitable prognostic prediction system for gallbladder cancer (GBC) is yet to be determined. This study aims to establish a combined score integrating preoperative patients' nutritional and immune status and pathological parameters to forecast the survival outcomes following curative-intent surgery of GBC.

METHODS

This retrospective study included patients diagnosed with GBC based on postoperative pathological examinations. The patients underwent curative surgery at West China Hospital of Sichuan University (China) between January 2014 and December 2022. Using the controlling nutritional status (CONUT) score and gallbladder cancer predictive risk score (GBRS), we generated the CONUT-GBRS for every patient, and the patients were divided into two groups based on the optimal cutoff value. Comparisons were made between the two groups regarding clinicopathologic features and survival.

RESULTS

The optimal cutoff value for the CONUT-GBRS was 1.39. There were 99 and 201 individuals in the high and low CONUT-GBRS groups, respectively. Patients with high CONUT-GBRS experienced poorer overall survival and disease-free survival compared with those with low CONUT-GBRS, even after propensity score matching analysis. Both univariate and multivariate Cox analyses established that CONUT-GBRS stood as an independent prognostic factor for GBC patients. Subgroup analysis indicated that CONUT-GBRS was also an effective predictor of prognosis in patients with incidental GBC.

CONCLUSION

The CONUT-GBRS serves as an advantageous, straightforward, and cost-effective prognostic tool for GBC, offering valuable prognostic insights and guiding the tailoring of individualized treatment strategies to improve patient outcomes.

摘要

背景

胆囊癌(GBC)最合适的预后预测系统尚未确定。本研究旨在建立一个综合评分,整合术前患者的营养和免疫状况以及病理参数,以预测GBC根治性手术后的生存结果。

方法

这项回顾性研究纳入了根据术后病理检查确诊为GBC的患者。2014年1月至2022年12月期间,这些患者在四川大学华西医院接受了根治性手术。我们使用控制营养状况(CONUT)评分和胆囊癌预测风险评分(GBRS),为每位患者生成CONUT-GBRS,并根据最佳临界值将患者分为两组。比较两组的临床病理特征和生存率。

结果

CONUT-GBRS的最佳临界值为1.39。CONUT-GBRS高分组和低分组分别有99例和201例患者。即使经过倾向评分匹配分析,CONUT-GBRS高的患者与CONUT-GBRS低的患者相比,总生存期和无病生存期更差。单因素和多因素Cox分析均表明,CONUT-GBRS是GBC患者的独立预后因素。亚组分析表明,CONUT-GBRS也是意外性GBC患者预后的有效预测指标。

结论

CONUT-GBRS是一种对GBC有利、简单且具有成本效益的预后工具,提供有价值的预后见解,并指导制定个体化治疗策略以改善患者预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3789/12426482/683db7ba5ec5/CAM4-14-e71203-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3789/12426482/7e9c86b8cdd5/CAM4-14-e71203-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3789/12426482/572cb9a1c0e8/CAM4-14-e71203-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3789/12426482/683db7ba5ec5/CAM4-14-e71203-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3789/12426482/7e9c86b8cdd5/CAM4-14-e71203-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3789/12426482/572cb9a1c0e8/CAM4-14-e71203-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3789/12426482/683db7ba5ec5/CAM4-14-e71203-g003.jpg

相似文献

1
Individualized Prognostic Insights: CONUT-GBRS for Survival Prediction in Gallbladder Cancer.个性化预后见解:用于胆囊癌生存预测的CONUT-GBRS
Cancer Med. 2025 Sep;14(18):e71203. doi: 10.1002/cam4.71203.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
4
Long-term prognosis of patients with gallbladder carcinoma after curative-intent resection based on changes in the ratio of carbohydrate antigen 19-9 to total bilirubin (CA19-9/TB): a multicenter retrospective cohort study.基于糖链抗原 19-9 与总胆红素比值(CA19-9/TB)变化的胆囊癌根治性切除术后患者的长期预后:一项多中心回顾性队列研究。
Int J Surg. 2024 Jun 1;110(6):3580-3590. doi: 10.1097/JS9.0000000000001379.
5
Application of systemic immune-inflammation index in survival prediction after radical resection of gallbladder cancer: A multicenter retrospective clinical study.全身免疫炎症指数在胆囊癌根治性切除术后生存预测中的应用:一项多中心回顾性临床研究
Eur J Surg Oncol. 2025 Jun 20;51(9):110267. doi: 10.1016/j.ejso.2025.110267.
6
Preoperative controlling nutritional status score for patients with medullary thyroid cancer.甲状腺髓样癌患者术前控制营养状况评分
Endocrine. 2025 May 10. doi: 10.1007/s12020-025-04233-8.
7
Prognostic Factors and Treatment Outcomes in Gallbladder Cancer Patients Undergoing Curative Surgery: A Multicenter Retrospective Cohort Study.接受根治性手术的胆囊癌患者的预后因素及治疗结果:一项多中心回顾性队列研究
Curr Oncol. 2025 Jun 3;32(6):328. doi: 10.3390/curroncol32060328.
8
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
9
Inflammatory and nutritional markers predict response and prognosis of patients with locally advanced gastric cancer receiving neoadjuvant immunochemotherapy.炎症和营养标志物可预测接受新辅助免疫化疗的局部晚期胃癌患者的反应和预后。
BMC Gastroenterol. 2025 Jul 1;25(1):478. doi: 10.1186/s12876-025-03874-3.
10
Impact of a novel immune and nutritional score on prognosis in patients with upper urinary tract urothelial carcinoma following radical nephroureterectomy.新型免疫和营养评分对根治性肾输尿管切除术治疗上尿路上皮癌患者预后的影响。
J Cancer Res Clin Oncol. 2023 Sep;149(12):10893-10909. doi: 10.1007/s00432-023-04977-8. Epub 2023 Jun 15.

本文引用的文献

1
Lymphovascular Invasion at the Time of Radical Prostatectomy Adversely Impacts Oncological Outcomes.根治性前列腺切除术时的淋巴管侵犯对肿瘤学结局有不利影响。
Cancers (Basel). 2023 Dec 26;16(1):123. doi: 10.3390/cancers16010123.
2
A Retrospective Multicenter Study of Risk Factors, Stratification, and Prognosis of Lymph Node Metastasis in T1 and T2 Colorectal Cancer.T1和T2期结直肠癌淋巴结转移危险因素、分层及预后的回顾性多中心研究
J Clin Med. 2023 Dec 18;12(24):7744. doi: 10.3390/jcm12247744.
3
Prognostic Significance of Tumor Necrosis in Patients with Gallbladder Carcinoma Undergoing Curative-Intent Resection.
肿瘤坏死对接受根治性切除术的胆囊癌患者的预后意义。
Ann Surg Oncol. 2024 Jan;31(1):125-132. doi: 10.1245/s10434-023-14421-3. Epub 2023 Oct 26.
4
Comparison of the effectiveness of chemotherapy combined with immunotherapy and chemotherapy alone in advanced biliary tract cancer and construction of the nomogram for survival prediction based on the inflammatory index and controlling nutritional status score.比较化疗联合免疫治疗与单纯化疗在晚期胆道癌中的疗效,并构建基于炎症指数和控制营养状况评分的生存预测列线图。
Cancer Immunol Immunother. 2023 Nov;72(11):3635-3649. doi: 10.1007/s00262-023-03513-4. Epub 2023 Sep 5.
5
Estimating the influencing factors for T1b/T2 gallbladder cancer on survival and surgical approaches selection.评估 T1b/T2 期胆囊癌对生存的影响因素及手术方式选择。
Cancer Med. 2023 Aug;12(16):16744-16755. doi: 10.1002/cam4.6297. Epub 2023 Jun 27.
6
The significance of peri-neural invasion in patients with gallbladder carcinoma after curative surgery: a 10 year experience in China.在中国,根治性手术后胆囊癌患者神经周围侵犯的意义:一项长达 10 年的经验。
Updates Surg. 2023 Aug;75(5):1123-1133. doi: 10.1007/s13304-023-01519-2. Epub 2023 Apr 26.
7
Gallbladder Cancer: Current Multimodality Treatment Concepts and Future Directions.胆囊癌:当前的多模态治疗理念与未来方向
Cancers (Basel). 2022 Nov 14;14(22):5580. doi: 10.3390/cancers14225580.
8
Gallbladder cancer.胆囊癌。
Nat Rev Dis Primers. 2022 Oct 27;8(1):69. doi: 10.1038/s41572-022-00398-y.
9
Endobiliary Ablation Combined with Immune Nutrition Improves Quality of Life: A Preliminary Clinical Study in Patients with Advanced Malignant Obstructive Jaundice.经内镜胆道消融联合免疫营养改善晚期恶性梗阻性黄疸患者生活质量的初步临床研究。
Med Sci Monit. 2022 Sep 15;28:e936863. doi: 10.12659/MSM.936863.
10
Clinicopathological prognostic factors for gallbladder carcinoma: a retrospective study.胆囊癌的临床病理预后因素:一项回顾性研究。
J Gastrointest Oncol. 2022 Aug;13(4):1997-2006. doi: 10.21037/jgo-22-61.